Penn State Clinician: 7-OH Addiction Sets In Within Two to Three Weeks of Regular Use

Why it matters

Penn State Health addiction specialists are now treating 7-OH patients using the same medications as opioid use disorder — and reporting it responds better than fentanyl. That clinical finding matters for the millions of people navigating sudden product bans without a treatment plan.

The big picture

As the DEA's temporary scheduling of concentrated 7-OH takes effect in August 2026, clinicians are encountering a wave of patients with significant physical dependence who did not know they were taking an opioid-equivalent substance. Penn State Health's Advancement in Recovery Program has been at the front line of this shift. The article draws on patient accounts and clinician expertise to explain what 7-OH is, how quickly dependence forms, and what treatment looks like — framing an opioid crisis story that starts in gas stations and vape shops.

Key findings

• Physical dependence on 7-OH can develop within two to three weeks of regular use, and cravings can begin within days
• One patient described going from a free sample to a $100-a-day habit in three months after a single dose produced a high identical to 80mg oxycodone
• 7-OH acts on the same brainstem receptors that control breathing, making overdose look identical to a prescription opioid overdose
• Buprenorphine treats 7-OH use disorder effectively — Penn State clinician Sarah Kawasaki says it ''works like a charm and completely extinguishes physical cravings''
• Unlike fentanyl patients, 7-OH patients can transition to buprenorphine treatment more straightforwardly
• Pennsylvania lawmakers have introduced bills to classify synthetic 7-OH as Schedule I and ban sales to minors

What they say

''It's the primary psychoactive compound found naturally in kratom, but it's been synthetically isolated and manufactured,'' explained Sarah Kawasaki, director of the Advancement in Recovery Program at Penn State Health Psychiatry and Behavioral Health. ''It works like a charm and completely extinguishes their physical cravings. It's an eminently treatable problem.''

Bottom line

7-OH creates opioid-level addiction faster than most patients expect — but buprenorphine treats it effectively, making access to care the central public health challenge as bans force users off the market.